Table 2 Basic characteristics of the FoCus subcohort stratified into subjects taking DPP4i (T2D + DPP4i), without DPP4i treatment (T2D-DPP4i) and healthy controls.
Categorical variasbles | T2D + DPP4i (n = 23) | T2D-DPP4i (n = 46) | Healthy controls (n = 46) | p-value (T2D + DPP4i vs. T2D-DPP4i) |
|---|---|---|---|---|
Sex | ||||
Male | 12 (52%) | 18 (39%) | 27 (59%) | 0.31 |
Female | 11 (48%) | 28 (61%) | 19 (41%) | |
Inflammatory bowel disease | ||||
Yes | 1 (4.3%) | 3 (6.5%) | 0 (0%) | 0.73 |
No | 22 (96%) | 43 (93%) | 46 (100%) | |
Cardian insufficiency | ||||
Yes | 2 (9.5%) | 6 (13%) | 0 (0%) | 0.67 |
No | 19 (90%) | 39 (87%) | 46 (100%) | |
Apoplexy | ||||
Yes | 2 (8.7%) | 1 (2.2%) | 0 (0%) | 0.26 |
No | 21 (91%) | 44 (98%) | 46 (100%) | |
Rheumatoid arthritis | ||||
Yes | 1 (4.3%) | 4 (9.5%) | 0 (0%) | 0.47 |
No | 22 (96%) | 38 (90%) | 46 (100%) | |
Neuropathy | ||||
Yes | 1 (4.8%) | 7 (17%) | 0 (0%) | 0.19 |
No | 20 (95%) | 35 (83%) | 46 (100%) | |
Periodontal disease | ||||
Yes | 8 (35%) | 17 (40%) | 0 (0%) | 0.71 |
No | 15 (65%) | 26 (60%) | 46 (100%) | |
Liver disease | ||||
Yes | 3 (13%) | 8 (17%) | 0 (0%) | 0.65 |
No | 20 (87%) | 38 (83%) | 46 (100%) | |
Myocardial infarction | ||||
Yes | 3 (14%) | 6 (13%) | 0 (0%) | 0.97 |
No | 19 (86%) | 40 (87%) | 46 (100%) | |
High blood lipids | ||||
Yes | 11 (50%) | 24 (56%) | 0 (0%) | 0.66 |
No | 11 (50%) | 19 (44%) | 46 (100%) | |
Hypertension | ||||
Yes | 18 (78%) | 35 (78%) | 0 (0%) | 0.97 |
No | 5 (22%) | 10 (22%) | 46 (100%) | |
